Best Muscle Relaxant for Acute Low Back Strain
Tizanidine is the best muscle relaxant for acute low back strain, with the strongest evidence base (8 clinical trials) and superior efficacy and safety profile compared to other options. 1
First-Line Treatment Approach
Start with NSAIDs (ibuprofen 600-800 mg three times daily or naproxen 500 mg twice daily) as the foundation of therapy, since NSAIDs are slightly more effective than acetaminophen for pain relief and provide moderate short-term efficacy. 2, 3
- If NSAIDs alone provide insufficient relief within 2-4 days, add tizanidine as the preferred muscle relaxant. 1
- The combination of tizanidine plus NSAIDs provides consistently greater short-term pain relief than monotherapy in high-quality trials. 1
Tizanidine Dosing
Begin with tizanidine 2-4 mg at bedtime or up to three times daily, titrating upward as needed for pain control. 1
- In older adults or those at higher risk for adverse effects, start with 2 mg up to three times daily. 1
- The combination increases CNS adverse events (drowsiness, dizziness) by 2.44-fold but reduces gastrointestinal adverse events by approximately half (RR 0.54) compared to NSAID monotherapy. 1
Why Not Other Muscle Relaxants?
Cyclobenzaprine is a reasonable alternative but has weaker evidence than tizanidine, with only one lower-quality trial for chronic low back pain that did not report pain intensity or global efficacy. 1 However, cyclobenzaprine 5 mg three times daily has been shown effective in multiple trials for acute low back pain, with efficacy independent of its sedative effects. 4, 5
- Cyclobenzaprine 5 mg three times daily is as effective as 10 mg three times daily but causes less sedation. 5
- One community-based trial found no additional benefit when combining cyclobenzaprine 5 mg with ibuprofen compared to cyclobenzaprine alone, though this conflicts with the guideline recommendation for tizanidine combination therapy. 6
Avoid these options:
- Methocarbamol: No evidence of efficacy in chronic pain and does not directly relax skeletal muscle. 1
- Baclofen: Only 2 trials for low back pain despite efficacy in spasticity; approved primarily for upper motor neuron disorders, not peripheral musculoskeletal pain. 2, 1, 7
- Benzodiazepines (diazepam): No proven benefit for musculoskeletal pain, high abuse potential, and substantially increase fall risk. 2, 1, 8
- Carisoprodol: Growing concern for abuse potential mitigates its usefulness. 9
Treatment Duration and Monitoring
Limit muscle relaxant therapy to 7-14 days maximum for acute pain, since no evidence supports efficacy beyond 2 weeks. 1, 7
- Monitor for sedation, dizziness, and hypotension—the most common dose-related adverse effects. 1
- Tizanidine requires monitoring for hepatotoxicity, which is generally reversible. 1
- Reassess within 2-4 days for acute pain relief; if no improvement occurs after a time-limited course, reconsider the diagnosis and alternative therapies. 1
Critical Pitfalls to Avoid
Do not prescribe muscle relaxants for chronic low back pain (>12 weeks), as no muscle relaxants have evidence of efficacy beyond acute use. 1, 7 For chronic pain, consider tricyclic antidepressants (amitriptyline) or duloxetine instead, which have moderate evidence for chronic pain. 2, 8
All skeletal muscle relaxants increase total adverse events (RR 1.50) and CNS adverse events (RR 2.04) compared to placebo, with drowsiness, dizziness, and fatigue being most common. 1 Communicate these risks clearly to patients and emphasize that these drugs do not directly relax skeletal muscle but likely work through sedative properties. 1, 10
Advise patients to remain active and avoid bed rest, as activity restriction prolongs recovery. 8 Muscle relaxants should complement—not replace—patient education about staying active.